Lead and cognitive function in VDR genotypes in the third National Health and Nutrition Examination Survey

Neurotoxicology and Teratology

Volumn 32, Issue 2, 2010, Pages 262-272

  Krieg Jr , Edward F ^a   Butler, Mary Ann ^a   Chang, Man huei ^b   Liu, Tiebin ^b   Yesupriya, Ajay ^b   Dowling, Nicole ^b   Lindegren, Mary Lou ^c  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Blood lead; Cognitive function; Homocysteine; NHANES III; VDR

Indexed keywords

CALCITRIOL RECEPTOR; HOMOCYSTEINE; LEAD;

ADOLESCENT; ADULT; AGED; AMINO ACID BLOOD LEVEL; ARITHMETIC; ARTICLE; CHILD; COGNITION; CONTROLLED STUDY; ETHNIC AND RACIAL GROUPS; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEAD BLOOD LEVEL; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN METABOLISM; WORD RECOGNITION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COGNITION; COGNITION DISORDERS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HEALTH STATUS; HEALTH SURVEYS; HOMOCYSTEINE; HUMANS; LEAD; LEAD POISONING, NERVOUS SYSTEM; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; YOUNG ADULT;

EID: 77649273081     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2009.12.004     Document Type: Article

References (47)

1. Audesirk G. Electrophysiology of lead intoxication: effects on voltage-sensitive ion channels. Neurotoxicology 14 (1993) 137-147
2. 3 selectively induces increased expression of the Na, K-ATPase β1 subunit in avian myelomonocytic cells without a concomitant change in Na, K-ATPase activity. J. Cell. Physiol. 172 (1997) 221-229
3. Brewer L.D., Thibault V., Chen K.C., Langub M.C., Landfield P.W., and Porter N.M. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J. Neurosci. 21 (2001) 98-108
4. Brown A.J., Dusso A., and Slatopolsky E. Vitamin D. Am. J. Physiol. 277 (1999) F157-F175
5. Burne T.H.J., McGrath J.J., Eyles D.W., and Mackay-Sim A. Behavioural characterization of vitamin D receptor knockout mice. Behav. Brain Res. 157 (2005) 299-308
6. Cartegni L., Chew S.L., and Krainer A.R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3 (2002) 285-298
7. 2+ channels. Annu. Rev. Cell Dev. Biol. 16 (2000) 521-555
8. Chang M., Lindegren M.L., Butler M.A., Chanock S.J., Dowling N.F., Gallagher M., Moonesinghe R., Moore C.A., Ned R.M., Reichler M.R., Sanders C.L., Welch R., Yesupriya A., Khoury M.J., and for the CDC/NCI NHANES III Genomics Working Group. Prevalence in the United States of selected candidate gene variants: third National Health and Nutrition Examination Survey, 1991-1994. Am. J. Epidemiol. 169 (2009) 54-66
9. 3 stimulated protein kinase C phosphorylation of type VI adenylyl cyclase inhibits parathyroid hormone signal transduction in rat osteoblastic UMR 106-01 cells. J. Cell. Biochem. 94 (2005) 1017-1027
10. Chuang H.Y., Yu K.T., Ho C.K., Wu M.T., Lin G.T., and Wu T.N. Investigations of vitamin D receptor polymorphism affecting workers' susceptibility to lead. J. Occup. Health 46 (2004) 316-322
11. Crawford D.C., and Nickerson D.A. Definition and clinical importance of haplotypes. Annu. Rev. Med. 56 (2005) 303-320
12. Cross H.S., Lipkin M., and Kállay E. Nutrients regulate the colonic vitamin D system in mice: relevance for human colon malignancy. J. Nutr. 136 (2006) 561-564
13. Dhonukshe-Rutten R.A.M., van Dusseldorp M., Schneede J., de Groot L.C.P.G.M., and van Staveren W.A. Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents. Eur. J. Nutr. 44 (2005) 341-347
14. 3. Mol. Cell. Endocrinol. 74 (1990) 143-153
15. 3 and intestinal vitamin D receptor concentrations in normal women. J. Clin. Endocrinol. Metab. 75 (1992) 176-182
16. Ewers U., and Erbe R. Effects of lead, cadmium and mercury on brain adenylate cyclase. Toxicology 16 (1980) 227-237
17. Eyles D.W., Smith S., Kinobe R., Hewison M., and McGrath J.J. Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. J. Chem. Neuroanat. 29 (2005) 21-30
18. Guallar E., Silbergeld E.K., Navas-Acien A., Malhotra S., Astor B.C., Sharrett A.R., and Schwartz B.S. Confounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium, and renal function. Am. J. Epidemiol. 163 (2006) 700-708
19. Gunter E.W., Lewis B.G., and Koncikowski S.M. Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 (1996), National Center for Health Statistics, Hyattsville, Maryland
20. 2+ in calmodulin. Arch. Toxicol. 54 (1983) 61-70
21. Haynes E.N., Kalkwarf H.J., Hornung R., Wenstrup R., Dietrich K., and Lanphear B.P. Vitamin D receptor Fok1 polymorphism and blood lead concentration in children. Environ. Health Perspect. 111 (2003) 1665-1669
22. Kalueff A.V., Lou Y.R., Laaksi I., and Tuohimaa P. Impaired motor performance in mice lacking neurosteroid vitamin D receptors. Brain Res. Bull. 64 (2004) 25-29
23. Kalueff A.V., Lou Y.R., Laaksi I., and Tuohimaa P. Increased anxiety in mice lacking vitamin D receptor gene. NeuroReport 15 (2004) 1271-1274
24. Kalueff A.V., Lou Y.R., Laaksi I., and Tuohimaa P. Increased grooming behavior in mice lacking vitamin D receptors. Physiol. Behav. 82 (2004) 405-409
25. Kato S., Kim M., Yamaoka K., and Fujiki R. Mechanisms of transcriptional repression by 1, 25(OH)2 vitamin D. Curr. Opin. Nephrol. Hypertens. 16 (2007) 297-304
26. Knight J.C. Regulatory polymorphisms underlying complex disease traits. J. Mol. Med. 83 (2005) 97-109
27. Krieg Jr. E.F., Chrislip D.W., Crespo C.J., Brightwell W.S., Ehrenberg R.L., and Otto D.A. The relationship between blood lead levels and neurobehavioral test performance in NHANES III and related occupational studies. Public Health Rep. 120 (2005) 240-251
28. 2+-ATPase by metal ions and prevention and recovery of inhibited activities by chelators. J. Enzyme Inhib. Med. Chem. 20 (2005) 469-476
29. Kuningas M., Mooijaart S.P., Jolles J., Slagboom P.E., Westendorp R.G.J., and van Heemst D. VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol. Aging 30 (2009) 466-473
30. Langman L.J., and Cole D.E.C. Homocysteine. Crit. Rev. Clin. Lab. Sci. 36 (1999) 365-406
31. Lanphear B.P., Dietrich K., Auinger P., and Cox C. Cognitive deficits associated with blood lead concentrations <10 μg/dL in US children and adolescents. Public Health Rep. 115 (2000) 521-529
32. Markovac J., and Goldstein G.W. Picomolar concentrations of lead stimulate brain protein kinase C. Nature 334 (1988) 71-73
33. McCaddon A. Homocysteine and cognition-a historical perspective. J Alzheimers Dis 9 (2006) 361-380
34. Morris M.S., Jacques P.F., Rosenberg I.H., and Selhub J. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 73 (2001) 927-933
35. 3. Mol. Cell. Endocrinol. 197 (2002) 1-13
36. 3 receptor: a network of coactivator interactions. Gene 246 (2000) 9-21
37. Rezende V.B., Barbosa Jr. F., Montenegro M.F., Sandrim V.C., Gerlach R.F., and Tanus-Santos J.E. Haplotypes of vitamin D receptor modulate the circulating levels of lead in exposed subjects. Arch. Toxicol. 82 (2008) 29-36
38. Schafer J.H., Glass T.A., Bressler J., Todd A.C., and Schwartz B.S. Blood lead is a predictor of homocysteine levels in a population-based study of older adults. Environ. Health Perspect. 113 (2005) 31-35
39. 3-treated chicks. Calcif. Tissue Int. 47 (1990) 46-50
40. Shi K., Guo R., Wang W., Ma H., and Yuan P. Association between vitamin D receptor gene polymorphism and the susceptibility of children to lead. Chin. J. Pediatr. 41 (2003) 751-754
41. Silbergeld E.K., and Adler H.S. Subcellular mechanisms of lead neurotoxicity. Brain Res. 148 (1978) 451-467
42. 2+-channel diversity, 1988-1994. Trends Neurosci. 18 (1995) 52-54
43. 3 regulates the expression of N-myc, c-myc, protein kinase C, and transforming growth factor-β2 in neuroblastoma cells. Biochem. Biophys. Res. Commun. 235 (1997) 15-18
44. Walters M.R. Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13 (1992) 719-764
45. 3. J Steroid Biochem 19 (1983) 913-920
46. Ye X.B., Wu C.E., Fu H., Yang S.L., Lu Y.W., and Ni W.M. Associations of blood lead levels, kidney function, and blood pressure with δ-aminolevulinic acid dehydratase and vitamin D receptor polymorphisms. Toxicol. Mech. Methods 13 (2003) 139-146
47. Zaykin D.V., Westfall P.H., Young S.S., Karnoub M.A., Wagner M.J., and Ehm M.G. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum. Hered. 53 (2002) 79-91